type 2 diabetes
CONCLUSIONS: There was evidence of over-utilization       of metformin and glibenclamide in type 2 diabetes patients most at risk of       adverse reactions.
CONCLUSIONS: There was evidence of over-utilization       of metformin and glibenclamide in  @SUBJECT$  @PREDICAT$  @OBJECT$  most at risk of       adverse reactions.